Anmelden

Dr. Selz - Dein Gesundheits-Podcast

Silent Inflammation - Wenn der Körper unter Dauerfeuer steht! #4

Sonntag, 12. April 2026 · 1 h 11

MP3

Shownotes

Ursachen, Warnsignale und Lösungen
🟢 Buch "Der Darm-Doc" - Vorbestellung & Gewinne (über 50.000 Euro)
👉🏻 der-darm-doc.de/jetzt-vorbestellen

🟢 Empfohlene Labortests: Darmflora & SIBO
doktorselz.de/labordiagnostikdaheim

🔴 Onlinekurs: Darmaufbau für Jedermann!
👉🏻 endlichdarmgesund.com/lpndarmaufbaukurs

🔴 Onlinekurs: Knack den SIBO-Code!
👉🏻 endlichdarmgesund.com/SIBO-Code

🔴 DarmExperts
👉🏻 doktorselz.de/darmxperts-nach-dr-selz

🟢 Holen Sie sich meine kostenlosen Hormon-Tipps!
👉🏻 doktorselz.de/quicktipps-hormone

🟢 Schritt-für-Schritt Anleitung zur Schwermetallausleitung
👉🏻 doktorselz.de/detox

🟢 Schritt-für-Schritt Anleitung zum Darmaufbau
👉🏻 doktorselz.de/freivondarmbeschwerden

Studien:
Xu Q, Lian H, Zhou R, Gu Z, Wu J, Wu Y and Li Z
(2025) Curcumin and multiple health outcomes: critical umbrella review of intervention meta-analyses., Front. Pharmacol. 16:1601204. doi: 10.3389/fphar.2025.1601204

Banait, T., Wanjari, A., Danade, V., Banait, S., & Jain, J. (2022). Role of High-Sensitivity C-reactive Protein (Hs-CRP) in Non-communicable Diseases: A Review. Cureus, 14. doi.org/10.7759/cureus.30225

Gough, A., Sitch, A., Ferris, E., & Marshall, T. (2024). Within-subject variation of C-reactive protein and high-sensitivity C-reactive protein: A systematic review and meta-analysis. PLOS ONE, 19. doi.org/10.1371/journal.pone.0304961

Driscoll et al. (2023). Antenatal, intrapartum and infant azithromycin to prevent stillbirths and infant deaths: study protocol for SANTE, a 2×2 factorial randomised controlled trial in Mali. BMJ Open, 13. doi.org/10.1136/bmjopen-2022-067581

Fioranelli et al. (2021). Regulation of Inflammatory Reaction in Health and Disease. International Journal of Molecular Sciences, 22. doi.org/10.3390/ijms22105277

Paunno et al. (2024). Stillbirth prevention with counseling during antenatal care visits in pregnant women: A systematic review. Science, Engineering and Health Studies. doi.org/10.69598/sehs.18.24050009

Cifuentes et al. (2024). Low-grade Chronic Inflammation: A Shared Mechanism for Chronic Diseases.. Physiology. doi.org/10.1152/physiol.00021.2024

Oh et al. (2019). Evidence that antibiotic administration is effective in the treatment of a subset of patients with intra-amniotic infection/inflammation presenting with cervical insufficiency.. American journal of obstetrics and gynecology. doi.org/10.1016/j.ajog.2019.03.017

Van De Vyver et al. (2023). Immunology of chronic low-grade inflammation: relationship with metabolic function.. The Journal of endocrinology. doi.org/10.1530/joe-22-0271

Xiang et al. (2025). Pulsatilla chinensis extract alleviate Staphylococcus aureus induced mastitis in mice by regulating the inflammatory response and gut microbiota. Frontiers in Veterinary Science, 12. doi.org/10.3389/fvets.2025.1603107

Ligthart et al. (2016). DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biology, 17. doi.org/10.1186/s13059-016-1119-5

Toth et al. (2020). Keratoconjunctivitis limbalis superior (KCLS) in the horse. Pferdeheilkunde Equine Medicine, 36, 488–494-488–494. doi.org/10.21836/pem20200601

Custodero et al. (2018). Evidencebased nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis. Ageing Research Reviews, 46, 42-59. doi.org/10.1016/j.arr.2018.05.004

Acer-Demir et al. (2025). Successful Treatment of Early Presenting Intussusception With a Single Dose of Corticosteroid: A Prospective Randomized Controlled Trial.. Journal of pediatric surgery, 60 4, 162198. doi.org/10.1016/j.jpedsurg.2025.162198

Fioranelli et al. (2017). Low-Dose Therapy for the Treatment of Low-Grade Chronic Inflammation. **, 27-38. doi.org/10.1007/978-3-319-40010-5_3

Özbek et al. (2025). Hidradenitis Suppurativa Treatment During Pregnancy and Lactation: Navigating Challenges. International Journal of Dermatology, 64, 1173 - 1185. doi.org/10.1111/ijd.17672

Fioranelli et al. (2024). Low-grade chronic inflammation and transcriptomics: how molecular pharmacognosy can help find new natural treatment alternatives—a narrative review. Beni-Suef University Journal of Basic and Applied Sciences, 13. doi.org/10.1186/s43088-024-00506-9

Sankawa et al. (2025). Neue Standards in der Behandlung gastrointestinaler Tumoren. Gastro-News, 12, 75 - 75. doi.org/10.1007/s15036-025-3960-4

Fullerton et al. (2016). Resolution of inflammation: a new therapeutic frontier. Nature Reviews Drug Discovery, 15, 551-567. doi.org/10.1038/nrd.2016.39

Lederer et al. (2023). Interstitielle Lungenerkrankungen. Zeitschrift Für Pneumologie, 1 - 12. doi.org/10.1007/s10405-023-00514-z

Soliman et al. (2025). Molecular dynamics of inflammation resolution: therapeutic implications. Frontiers in Cell and Developmental Biology, 13. doi.org/10.3389/fcell.2025.1600149

Yoon et al. (2019). Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes.. American journal of obstetrics and gynecology. doi.org/10.1016/j.ajog.2019.03.018

Park et al. (2010). Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutrition & Metabolism, 7, 18 - 18. doi.org/10.1186/1743-7075-7-18

Youssef et al. (2025). The anti-inflammatory and antioxidant effects of astaxanthin as an adjunctive therapy in community-acquired pneumonia: a randomized controlled trial. Frontiers in Pharmacology, 16. doi.org/10.3389/fphar.2025.1621308

Chang et al. (2020). Astaxanthin and its Effects in Inflammatory Responses and Inflammation-Associated Diseases: Recent Advances and Future Directions. Molecules, 25. doi.org/10.3390/molecules25225342

Davinelli et al. (2022). Astaxanthin as a Modulator of Nrf2, NF-κB, and Their Crosstalk: Molecular Mechanisms and Possible Clinical Applications. Molecules, 27. doi.org/10.3390/molecules27020502

Kohandel et al. (2021). Anti-inflammatory action of astaxanthin and its use in the treatment of various diseases.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 145, 112179. doi.org/10.1016/j.biopha.2021.112179

Pereira et al. (2020). Antioxidant and anti-inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review). International Journal of Molecular Medicine, 47, 37 - 48. doi.org/10.3892/ijmm.2020.4783

Youssef et al. (2025). The anti-inflammatory and antioxidant effects of astaxanthin as an adjunctive therapy in community-acquired pneumonia: a randomized controlled trial. Frontiers in Pharmacology, 16. doi.org/10.3389/fphar.2025.1621308

Davinelli et al. (2022). Astaxanthin as a Modulator of Nrf2, NF-κB, and Their Crosstalk: Molecular Mechanisms and Possible Clinical Applications. Molecules, 27. doi.org/10.3390/molecules27020502

Farruggia et al. (2018). Astaxanthin exerts anti-inflammatory and antioxidant effects in macrophages in NRF2-dependent and independent manners.. The Journal of nutritional biochemistry, 62, 202-209. doi.org/10.1016/j.jnutbio.2018.09.005

Calder et al. (2010). Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions, 38, 211–215. doi.org/10.1042/BST0380211

Rangel-Huerta et al. (2012). Omega-3 long-chain polyunsaturated fatty acids and inflammatory biomarkers in healthy subjects: a systematic review and meta-analysis of randomized controlled trials. The British Journal of Nutrition, 107, S159–S170. doi.org/10.1017/S0007114512001556

Haftungsausschluss
Sämtliche in diesem Video/ Audio enthaltene medizinische Inhalte dienen lediglich der …

Anmelden oder registrieren

Jetzt

0:00 / 0:00